NHS to offer breast cancer drugs to women at risk

Hundreds of thousands of women at risk of breast cancer will be offered drugs to prevent them developing the disease in a 'fundamental change' to NHS care.

Women aged 40-69 with BRCA mutations should be screened annually for breast cancer, NICE has said (Photo: iStock)
Women aged 40-69 with BRCA mutations should be screened annually for breast cancer, NICE has said (Photo: iStock)

Tamoxifen or raloxifene should be offered to women who face a greater risk of developing breast cancer because of their family history, according to NICE.

The drugs are not licensed for preventive treatment in the UK, but NICE said evidence showed they are an effective alternative to mastectomy to prevent the disease.

The Scottish government announced it would introduce a similar scheme.

About 488,000 women in England and Wales - 3% of those aged 35 and older - face a higher risk of breast cancer due to their family history, and about 10,000 cases a year are diagnosed among this group.

Preventive drug treatment for five years will give some women an alternative to what can be 'traumatic' surgery to remove their breasts, NICE said.

The threshold for genetic testing has also been significantly lowered, while routine screening for high-risk patients will be stepped up.

Charities hailed the decision as a 'truly historic moment' in breast cancer care.

NICE's guidance recommends:

  • Secondary care doctors should calculate a patient's risk of possessing the faulty BRCA genes, and decide whether to offer genetic testing.
  • Testing should now be offered to relatives if their chance of carrying the mutations is 10% or more - half the previous level.
  • Annual mammography and MRI will be offered to a larger number of women at risk.

England's national clinical director for cancer, Sean Duffy, said the guidance offered a 'further dimension' to the options for women at risk of breast and ovarian cancers.

Baroness Delyth Morgan, chief executive of Breast Cancer Campaign, said: 'This is a truly historic moment in the treatment of women at increased risk of breast cancer, as we are witnessing a fundamental change of clinical practice driven by medical research.'

Dr Caitlin Palframan, assistant head of policy at Breakthrough Breast Cancer, said: 'Today’s new guidelines are a game changer in the way we prevent breast cancer. Our strongest tool in the fight against breast cancer is prevention, and these new guidelines are a fantastic leap forward in the way we prevent breast cancer developing in those at highest risk.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...